<DOC>
	<DOC>NCT00303017</DOC>
	<brief_summary>safety, efficacy and acceptability of Flavocoxid</brief_summary>
	<brief_title>Safety, Efficacy and Acceptability of Flavocoxid (Limbrel)A Pilot Study</brief_title>
	<detailed_description>Safety, Efficacy and acceptability of Flavocoxid (Limbrel) compared with Naproxen in Subjects with Osteoarthritis of the Knee. A Pilot Study</detailed_description>
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>OA of the knee,KL grade 23 in general good health is currently taking an NSAID or COX2 inhibitor pregant or nursing women grade 1 or 4 OA any significant medical condition that in the opinion of the physician might put the subject at risk in this study any form of arthropathy other than OA any condition that might confound the evaluation of the pain, stiffness or function of the target joint intraarticular cotticosteroid inkection in the target joint within 3 month of the screening visit concomitant use of other antiinflammatory or anti arthritic medication or products(including OTC and herbal preparations) Low dose aspirin for cardioprotection is allowed concomitant use of coumadin or other anticoagulant or antiplatelet medication concomitant use of gastroprotectiv medications including, but not limited to, H2 blockers and proton pump inhibitors, including OTC and herbal products History of allergy to Flavonoids</criteria>
	<gender>All</gender>
	<minimum_age>30 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>November 2008</verification_date>
</DOC>